NSE filing, NSE: KALYANKJIL. Summary written from the filing by ALFA Finder's alert engine.
Kalyan Jewellers India Ltd: key numbers
- Share price
- ₹510.00
- Market cap
- ₹52,670 Cr
- Revenue (annual)
- ₹35,743 Cr
- Net profit (annual)
- ₹1,350 Cr
- P/E (TTM)
- 36.7×Sector 49.0×
- Promoter holding
- 62.85%-0.01% QoQ
- FII holding
- 13.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kalyan Jewellers India Ltd
All →Kalyan Jewellers India Board Meeting Date
Kalyan Jewellers scheduled its Board meeting for November 10, 2026 to approve un-audited Q2 and H1 FY27 results. No financial figures or decisions are disclosed in this intimation.
Kalyan Jewellers India Other Announcement
Kalyan Jewellers India Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Kalyan Jewellers India Business Update
Kalyan Jewellers reported Q2 FY2027 revenue growth exceeding 26%. The company also completed the sale of a non-core real estate asset for ₹86 Crore.
- Value
- ₹86.00 Cr
Kalyan Jewellers India Merger & Restructuring Worth ₹86.16 Cr
Kalyan Jewellers India Limited sold an undertaking to Shivasakthi Real Estates for ₹86.16 Crore. This cash transaction was executed at arm's length on September 30, 2026.
- Value
- ₹86.16 Cr
Kalyan Jewellers India Credit Rating
India Ratings reaffirmed the credit ratings for Kalyan Jewellers India Limited’s bank facilities as IND AA-/Positive and IND A1+.
Kalyan Jewellers India Merger & Restructuring Worth ₹350 Cr
Kalyan Jewellers invested ₹350 Crore in its wholly-owned subsidiary, Candere Lifestyle Jewellery, via a rights issue. The funds will be used for loan repayment.
- Value
- ₹350.0 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date